General Biotechnology

How Brand-Name Drug Companies Delay Generic Competition: Product Hopping, Patent Thickets, and Market Exclusivity Tactics Explained

What if generic competition isnt a race to the finish linebut a game of scheduled delays?
For years, the public narrative around brand-name drug companies has been simple: patents exist to reward innovation. But dig into how modern pharmaceutical compe…

How Brand-Name Drug Companies Delay Generic Competition: Product Hopping, Patent Thickets, and Market Exclusivity Tactics Explained Read Post »

Biotechblog
Scroll to Top